Medulloblastoma and Down Syndrome: An Extremely Rare Association
- PMID: 35704799
- DOI: 10.1097/MPH.0000000000002448
Medulloblastoma and Down Syndrome: An Extremely Rare Association
Abstract
Medulloblastoma has a reduced incidence in Down syndrome (DS). This protective characteristic has not been clarified yet. Here, we report the second case of SHH medulloblastoma and DS documented in the literature. A complete surgery was performed followed by reduced craniospinal irradiation dose and adjuvant chemotherapy. No evidence of tumor recurrence was observed. The overall survival was 9.1 years. No family history or physical stigma of other hereditary predisposition syndrome was found. In the elucidation of this extremely rare association, future case reports play an important role in defining the spectrum of brain tumors and their peculiar features in DS.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflict of interest.
References
REFERENCE
-
- Roizen NJ, Patterson D. Down’s syndrome. Lancet. 2003;361:1281–1289.
-
- Rabin KR, Whitlock JA. Malignancy in children with trisomy 21. Oncologist. 2009;14:164–173.
-
- Shimada A. Profile of Down syndrome–associated malignancies: epidemiology, clinical features and therapeutic aspects. Pediatr Hematol Oncol J. 2021;6:63–72.
-
- Bruwier A, Chantrain CF. Hematological disorders and leukemia in children with Down syndrome. Eur J Pediatr. 2012;171:1301–1307.
-
- Nižetić D, Groet J. Tumorigenesis in Down’s syndrome: big lessons from a small chromosome. Nat Rev Cancer. 2012;2:721–732.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical